Table 1.

Clinical findings in patients with COVID-19 who underwent kidney biopsy

PtAgeSexRaceComorbiditiesISTemperature, °CSpO2 on RABPEdemaCOVID-19 ManifestationsRenal Presentation/Biopsy Indications
146MBOSA, obesity (BMI=44)N37.194144/100YCough, fever, sore throatAKI, NS
262MBHTN, prostate carcinomaN37.298126/79YFever, myalgia, weaknessAKI on CKD, NS
362MBHTN, DM, prostate carcinomaN36.891122/82NFever, hypoxemia, bilateral perihilar and basilar infiltrates on CXRAKI, NRP
457MBHTN, untreated hepatitis C virusN38.197173/92NFlu-like symptoms with ground glass opacities and patchy consolidation on CXRAKI on CKD, NRP
561MBHTN, obesity (BMI=31.1)N38.599134/79NCough, feverAKI, NRP
625MBObesity (BMI=32.2)N38.595117/79YCough, fever, myalgia, infiltrates on CXRAKI, NS
743FBDM, HLD, streptococcal infection, obesity (BMI=52.5)N37.696107/67NCough, fever, sore throat, weakness, patchy LUL infiltrates on CXRAKI
828MBNoneN38.696 (on O2)143/62NCough, fever, hypoxemia, bilateral infiltrates on CXR, elevated troponin and CPKAKI
967MWHTN, gout, history of tobacco use, obesity (BMI=34.9)N36.595135/75NCough, diarrhea, lethargy, multifocal infiltrates on CXRAKI on CKD
1051MBHTN, DSA+ OHTx for NICM 1 yr ago, atrial fibrillation, CVA, BPH, HLDY36.896117/81NPredominantly nausea, vomiting, abdominal pain, with coughAKI on CKD
1172MWHTN, DM, HLD, gout, spinal stenosis, atrial fibrillationN36.897 (on O2)125/73YCough, pleural effusion on CTNS
1270FBHTN, CAD, PVD, cervical carcinoma, GERD, HLD, obesity (BMI=39.4)N38.192118/58YCough, fever, shortness of breathAKI, NRP
1327FASLE with class 2 lupus nephritisY36.993130/80YCough, fever, shortness of breath, hypoxemia, bilateral infiltrates on CXR, required intubation and ICU admissionAKI, NS
1448FBGERD, history of tobacco use, obesityN37.698185/80NCough, myalgia, infiltrates on CXRAKI
1554MWESKD secondary to IgAN s/p DSA+ LURTx 1 mo ago, HTN, obesity (BMI=30.7)Y36.899116/75NAsymptomaticAKI
1622MBESKD likely secondary to PLA2R+ MGN s/p DDRTx 2 years ago, HTNY37.795178/127NCough, fever, bilateral infiltrates on CXR, required intubation and ICU admissionCKD
1754FHESKD secondary to PCKD s/p DDRTx 2 months ago, HTNY98.8100104/70NFever, dry throatAKI
  • BP is in millimeters of Hg. Pt, patient; IS, immunosuppression at presentation; SpO2, oxygen saturation (percentage); RA, room air; M, man; B, black; OSA, obstructive sleep apnea; BMI, body mass index; N, no; Y, yes; NS, nephrotic syndrome; HTN, hypertension; AKI on CKD, AKI superimposed on CKD; DM, diabetes mellitus; CXR, chest x-ray; NRP, nephrotic-range proteinuria; F, woman; HLD, hyperlipidemia; LUL, left upper lobe; O2, oxygen; CPK, creatine phosphokinase; W, white; DSA, donor-specific antibody; OHTx, orthotopic heart transplantation; NICM, nonischemic cardiomyopathy; CVA, cerebrovascular accident; BPH, benign prostatic hyperplasia; CT, computed tomography; CAD, coronary artery disease; PVD, peripheral vascular disease; GERD, gastroesophageal reflux disease; A, Asian; ICU, intensive care unit; IgAN, IgA nephropathy; s/p, status post; LURTx, living unrelated renal transplantation; MGN, membranous glomerulopathy; DDRTx, deceased donor renal transplantation; H, Hispanic; PCKD, polycystic kidney disease.